Log In
BCIQ
Print this Print this
 

Topofen (ELS-M11)

  Manage Alerts
Collapse Summary General Information
Company Achelios Therapeutics Inc.
DescriptionTopical gel formulation of 5% ketoprofen, an NSAID
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationMigraine
Indication DetailsTreat moderate to severe migraine
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today